(Circulation. 1996;94:3155-3160.)
© 1996 American Heart Association, Inc.
Articles |
Influence of Isoproterenol and Ouabain on Excitation-Contraction Coupling, Cross-Bridge Function, and Energetics in Failing Human Myocardium
the Medizinische Klinik III (G.H., H.J.), Universitat Freiburg, FRG; Department of Physiology and Biophysics (L.A.M., N.R.A.), University of Vermont, Burlington; and Department of Anesthesiology (P.D.A.), Brigham and Women's Hospital, Boston, Mass.
Correspondence to Gerd Hasenfuss, MD, Medizinische Klinik III, Universitat Freiburg, Hugstetter Str 55, 79106 Freiburg, FRG. E-mail hasenfus@ruf.uni-freiburg.de.
Background In patients with heart failure, long-term treatment with catecholamines and phosphodiesterase inhibitors, both of which increase cyclic AMP levels, may be associated with increased mortality, whereas mortality may not be increased with glycoside treatment. Differences in clinical benefit between cyclic AMP–dependent inotropic agents and cardiac glycosides may be related to differences of these drugs on calcium cycling and myocardial energetics.
Methods and Results Isometric heat and force measurements were used to investigate the effects of isoproterenol and ouabain on myocardial performance, cross-bridge function, excitation-contraction coupling, and energetics in myocardium from end-stage failing human hearts. Isoproterenol (1 µmol/L) increased peak twitch tension by 55% and decreased time to peak tension and relaxation time by 30% and 26%, respectively (P<.005). Ouabain (0.38±0.11 µmol/L) increased peak twitch tension and relaxation time by 41% and 20%, respectively, and decreased time to peak tension by 12% (P<.05). With isoproterenol, the amount of excitation-contraction coupling–related heat evolution (tension-independent heat) increased by 246% (P<.05) and the economy of excitation-contraction coupling decreased by 61% (P<.05). Ouabain increased tension-independent heat by only 61% (P<.05) and did not significantly influence economy of excitation-contraction coupling. The effects of isoproterenol on excitation-contraction coupling resulted in a 21% (P<.005) decrease of overall contraction economy, which was not significantly changed with ouabain. Neither isoproterenol nor ouabain influenced energetics of cross-bridge cycling or recovery metabolism.
Conclusions Major differences between the effects of isoproterenol and ouabain in failing human myocardium are related to calcium cycling with secondary effects on myocardial energetics.
Key Words: myocardium • calcium • heart failure • inotropic agents • catecholamines
This article has been cited by other articles:
 |
|
 |
|
  M. Kang, K. Y. Chung, and J. W. Walker G-Protein Coupled Receptor Signaling in Myocardium: Not for the Faint of Heart Physiology, June 1, 2007; 22(3): 174 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Montgomery, V. L. M. Rundell, P. H. Goldspink, D. Urboniene, D. L. Geenen, P. P. de Tombe, and P. M. Buttrick Protein kinase C{varepsilon} induces systolic cardiac failure marked by exhausted inotropic reserve and intact Frank-Starling mechanism Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1881 - H1888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nassar, N. N. Malouf, L. Mao, H. A. Rockman, A. E. Oakeley, J. R. Frye, J. R. Herlong, S. P. Sanders, and P. A. W. Anderson cTnT1, a cardiac troponin T isoform, decreases myofilament tension and affects the left ventricular pressure waveform Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1147 - H1156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Savio-Galimberti, P. Dos Santos Costa, A. C. Campos de Carvalho, and J. E. Ponce-Hornos Mechanical and energetic effects of chronic chagasic patients' antibodies on rat myocardium Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1239 - H1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Reiken, M. Gaburjakova, S. Guatimosim, A. M. Gomez, J. D'Armiento, D. Burkhoff, J. Wang, G. Vassort, W. J. Lederer, and A. R. Marks Protein Kinase A Phosphorylation of the Cardiac Calcium Release Channel (Ryanodine Receptor) in Normal and Failing Hearts. ROLE OF PHOSPHATASES AND RESPONSE TO ISOPROTERENOL J. Biol. Chem., January 3, 2003; 278(1): 444 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-P. Hermann, O. Zeitz, S. E Lehnart, B. Keweloh, N. Datz, G. Hasenfuss, and P. M.L Janssen Potentiation of beta-adrenergic inotropic response by pyruvate in failing human myocardium Cardiovasc Res, January 1, 2002; 53(1): 116 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Nieminen, J. Akkila, G. Hasenfuss, F. X. Kleber, L. A. Lehtonen, V. Mitrovic, O. Nyquist, W. J. Remme, and on behalf of the Study Group Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1903 - 1912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-P. Hermann, O. Zeitz, B. Keweloh, G. Hasenfuss, and P. M. L. Janssen Pyruvate potentiates inotropic effects of isoproterenol and Ca2+ in rabbit cardiac muscle preparations Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H702 - H708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Litwin, D. Zhang, P. Roberge, and G. D. Pennock DITPA prevents the blunted contraction-frequency relationship in myocytes from infarcted hearts Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H862 - H870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S Maier, C. Schwan, W. Schillinger, K. Minami, U. Schutt, and B. Pieske Gingerol, isoproterenol and ouabain normalize impaired post-rest behavior but not force-frequency relation in failing human myocardium Cardiovasc Res, March 1, 2000; 45(4): 913 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. I. Miyamoto, F. del Monte, U. Schmidt, T. S. DiSalvo, Z. B. Kang, T. Matsui, J. L. Guerrero, J. K. Gwathmey, A. Rosenzweig, and R. J. Hajjar Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure PNAS, January 18, 2000; 97(2): 793 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Kirchhefer, W. Schmitz, H. Scholz, and J. Neumann Activity of cAMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts Cardiovasc Res, April 1, 1999; 42(1): 254 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Hauptman and R. A. Kelly Digitalis Circulation, March 9, 1999; 99(9): 1265 - 1270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Shimizu, J. Araki, J. Mizuno, S. Lee, Y. Syuu, S. Hosogi, S. Mohri, T. Mikane, M. Takaki, T. W. Taylor, et al. A new integrative method to quantify total Ca2+ handling and futile Ca2+ cycling in failing hearts Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2325 - H2333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M Shah, S. J Sollott, and E. G Lakatta Physio-pharmacological evaluation of myocardial performance: an integrative approach Cardiovasc Res, July 1, 1998; 39(1): 148 - 154. [Full Text] [PDF]
|
|